NCT02481310 2022-02-21
Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma
Northwestern University
Phase 1/2 Unknown
Northwestern University
Alliance for Clinical Trials in Oncology
NSABP Foundation Inc
M.D. Anderson Cancer Center